Advertisement

Bronchiolitis Obliterans Syndrome in Children

  • Paul D. RobinsonEmail author
  • Paul Aurora
Chapter
Part of the Respiratory Medicine book series (RM, volume 8)

Abstract

Extrapolation of adult-based evidence into pediatric management decisions is often unavoidable owing to a lack of sufficiently powered, suitably designed pediatric studies. Pediatric data are emerging but are challenged by the lower numbers of lung and heart–lung transplants performed annually as compared to adult transplantation. Pediatric data are further diluted by the relatively large number of centers that perform pediatric transplants internationally. This chapter will discuss available pediatric data to illustrate the similarities that exist between pediatric and adult subjects with respect to incidence, risk factors, diagnosis, and management of bronchiolitis obliterans (BO). Although the pediatric lung transplant literature generally supports the use of data that are extrapolated from lung transplantation in adults, specific challenges also exist that are unique to the pediatric age range, and the resultant differences in approach are outlined.

Keywords

Pediatric Extrapolation Lung function Diagnosis Risk factors Management 

References

  1. 1.
    Benden C, Aurora P, Edwards LB, Kucheryavaya AY, Christie JD, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: Fourteenth pediatric lung and heart-lung transplantation report–2011. J Heart Lung Transplant. 2011;30(10):1123–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Aurora P, Edwards LB, Kucheryavaya AY, Christie JD, Dobbels F, Kirk R, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirteenth official pediatric lung and heart-lung transplantation report–2010. J Heart Lung Transplant. 2010;29(10):1129–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Nevins TE. Non-compliance and its management in teenagers. Pediatr Transplant. 2002;6(6): 475–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Shellmer DA, Dabbs AD, Dew MA. Medical adherence in pediatric organ transplantation: what are the next steps? Curr Opin Organ Transplant. 2011;16(5):509–14.PubMedCrossRefGoogle Scholar
  5. 5.
    Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R, et al. The registry of the International Society for Heart and Lung Transplantation: Twenty-eighth adult lung and heart-lung transplant report–2011. J Heart Lung Transplant. 2011;30(10):1104–22.PubMedCrossRefGoogle Scholar
  6. 6.
    Woo MS, MacLaughlin EF, Horn MV, Szmuszkovicz JR, Barr ML, Starnes VA. Bronchiolitis obliterans is not the primary cause of death in pediatric living donor lobar lung transplant recipients. J Heart Lung Transplant. 2001;20(5):491–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Dipchand AI, Pollock BarZiv SM, Manlhiot C, West LJ, VanderVliet M, et al. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant. 2010;10(2):389–97.PubMedCrossRefGoogle Scholar
  8. 8.
    Grasemann H, de Perrot M, Bendiak GN, Cox P, van Arsdell GS, Keshavjee S, et al. ABO-incompatible lung transplantation in an infant. Am J Transplant. 2012;12(3):779–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Fan X, Ang A, Pollock-Barziv SM, Dipchand AI, Ruiz P, Wilson G, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med. 2004;10(11): 1227–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Takahashi K. Accommodation in ABO-incompatible kidney transplantation: why do kidney grafts survive? Transplant Proc. 2004;36(2 Suppl):193S–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Ishida H, Tanabe K, Ishizuka T, Furusawa M, Miyamoto N, Ishikawa N, et al. The mechanism responsible for accommodation after living-related kidney transplantations across the blood barrier. Transpl Int. 2005;18(6):716–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Sweet SC. Pediatric lung transplantation. Proc Am Thorac Soc. 2009;6(1):122–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Barr ML, Kawut SM, Whelan TP, Girgis R, Bottcher H, Sonett J, et al. Report of the ISHLT Working Group on primary lung graft dysfunction part IV: recipient-related risk factors and markers. J Heart Lung Transplant. 2005;24(10):1468–82.PubMedCrossRefGoogle Scholar
  14. 14.
    Meyers BF, de la Morena M, Sweet SC, Trulock EP, Guthrie TJ, Mendeloff EN, et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg. 2005;129(6):1421–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007;175(5):507–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Hachem RR, Khalifah AP, Chakinala MM, Yusen RD, Aloush AA, Mohanakumar T, et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005;80(10):1406–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, et al. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med. 2004;170(9):1022–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Benden C, Faro A, Worley S, Arrigain S, Aurora P, Ballmann M, et al. Minimal acute rejection in pediatric lung transplantation–does it matter? Pediatr Transplant. 2010;14(4):534–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Shah N, Force SD, Mitchell PO, Lin E, Lawrence EC, Easley K, et al. Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts. Transplant Proc. 2010;42(7):2702–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17(4): 363–8.PubMedCrossRefGoogle Scholar
  21. 21.
    King BJ, Iyer H, Leidi AA, Carby MR. Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective. J Heart Lung Transplant. 2009;28(9):870–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliott MJ. High prevalence of gastroesophageal reflux in children after lung transplantation. Pediatr Pulmonol. 2005;40(1):68–71.PubMedCrossRefGoogle Scholar
  23. 23.
    Khalifah AP, Hachem RR, Chakinala MM, Schechtman KB, Patterson GA, Schuster DP, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med. 2004;170(2):181–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Kumar D, Erdman D, Keshavjee S, Peret T, Tellier R, Hadjiliadis D, et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant. 2005;5(8):2031–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Liu M, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, et al. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis. 2009;11(4):304–12.PubMedCrossRefGoogle Scholar
  26. 26.
    Patel N, Snyder LD, Finlen-Copeland A, Palmer SM. Is prevention the best treatment? CMV after lung transplantation. Am J Transplant. 2012;12(3):539–44.PubMedCrossRefGoogle Scholar
  27. 27.
    Duncan SR, Grgurich WF, Iacono AT, Burckart GJ, Yousem SA, Paradis IL, et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med. 1994;150(1):146–52.PubMedCrossRefGoogle Scholar
  28. 28.
    Engelmann I, Welte T, Fuhner T, Simon AR, Mattner F, Hoy L, et al. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. J Clin Virol. 2009;45(1):47–53.PubMedCrossRefGoogle Scholar
  29. 29.
    Epstein-Barr Virus and Infectious Mononucleosis. National Center for Infectious Diseases [1st May 2012]. http://www.cdc.gov/ncidod/diseases/ebv.htm.
  30. 30.
    Cano JR, Cerezo F, Algar FJ, Alvarez A, Espinosa D, Moreno P, et al. Prognostic factors influencing survival rates in children following lung transplantation. Transplant Proc. 2008;40(9):3070–2.PubMedCrossRefGoogle Scholar
  31. 31.
    De Perrot M, Waddell TK, Shargall Y, Pierre AF, Fadel E, Uy K, et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg. 2007;133(2):525–31.PubMedCrossRefGoogle Scholar
  32. 32.
    Benden C, Harpur-Sinclair O, Ranasinghe AS, Hartley JC, Elliott MJ, Aurora P. Surveillance bronchoscopy in children during the first year after lung transplantation: is it worth it? Thorax. 2007;62(1):57–61.PubMedCrossRefGoogle Scholar
  33. 33.
    Faro A, Visner G. The use of multiple transbronchial biopsies as the standard approach to evaluate lung allograft rejection. Pediatr Transplant. 2004;8(4):322–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Linnane B, Hafen GM, Ranganathan SC. Diameter of pediatric sized flexible bronchoscopes: when size matters. Pediatr Pulmonol. 2006;41(8):787–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Visner GA, Faro A, Zander DS. Role of transbronchial biopsies in pediatric lung diseases. Chest. 2004;126(1):273–80.PubMedCrossRefGoogle Scholar
  36. 36.
    Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant. 2002;21(10):1062–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Weill D, McGiffin DC, Zorn Jr GL, Alexander CB, Early LJ, Kirklin JK, et al. The utility of open lung biopsy following lung transplantation. J Heart Lung Transplant. 2000;19(9): 852–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Sritippayawan S, Keens TG, Horn MV, MacLaughlin EF, Barr ML, Starnes VA, et al. Does lung growth occur when mature lobes are transplanted into children? Pediatr Transplant. 2002;6(6):500–4.PubMedCrossRefGoogle Scholar
  39. 39.
    Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21(3): 297–310.PubMedCrossRefGoogle Scholar
  40. 40.
    Stanojevic S, Wade A, Cole TJ, Lum S, Custovic A, Silverman M, et al. Spirometry centile charts for young Caucasian children: the asthma UK collaborative initiative. Am J Respir Crit Care Med. 2009;180(6):547–52.PubMedCrossRefGoogle Scholar
  41. 41.
    Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008;177(3): 253–60.PubMedCrossRefGoogle Scholar
  42. 42.
    Stocks J, Modi N, Tepper R. Need for healthy control subjects when assessing lung function in infants with respiratory disease. Am J Respir Crit Care Med. 2010;182(11):1340–2.PubMedCrossRefGoogle Scholar
  43. 43.
    Aurora P, Stocks J, Oliver C, Saunders C, Castle R, Chaziparasidis G, et al. Quality control for spirometry in preschool children with and without lung disease. Am J Respir Crit Care Med. 2004;169(10):1152–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Sritippayawan S, Keens TG, Horn MV, Starnes VA, Woo MS. What are the best pulmonary function test parameters for early detection of post-lung transplant bronchiolitis obliterans syndrome in children? Pediatr Transplant. 2003;7(3):200–3.PubMedCrossRefGoogle Scholar
  45. 45.
    Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, et al. An official American thoracic society/European respiratory society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007;175(12):1304–45.PubMedCrossRefGoogle Scholar
  46. 46.
    Cook RC, Fradet G, Muller NL, Worsely DF, Ostrow D, Levy RD. Noninvasive investigations for the early detection of chronic airways dysfunction following lung transplantation. Can Respir J. 2003;10(2):76–83.PubMedGoogle Scholar
  47. 47.
    Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277–84.PubMedCrossRefGoogle Scholar
  48. 48.
    Jaffe A, Hamutcu R, Dhawan RT, Adler B, Rosenthal M, Bush A. Routine ventilation scans in children with cystic fibrosis: diagnostic usefulness and prognostic value. Eur J Nucl Med. 2001;28(9):1313–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Haberman B, Doan ML, Smith EO, Schecter MG, Mallory GB, Elidemir O. Serum KL-6 level and the development of bronchiolitis obliterans syndrome in lung transplant recipients. Pediatr Transplant. 2010;14(7):903–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Silkoff PE, Caramori M, Tremblay L, McClean P, Chaparro C, Kesten S, et al. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1822–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Verleden GM, Dupont LJ, Van Raemdonck DE, Vanhaecke J. Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2004;78(5):730–3.PubMedCrossRefGoogle Scholar
  52. 52.
    Federica M, Nadia S, Monica M, Alessandro C, Tiberio O, Francesco B, et al. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. Clin Transplant. 2011;25(4):E381–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Verleden GM, Verleden SE, Vos R, De Vleeschauwer SI, Dupont LJ, Van Raemdonck DE, et al. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. Transpl Int. 2011;24(7):651–6.PubMedCrossRefGoogle Scholar
  54. 54.
    Johnson BA, Iacono AT, Zeevi A, McCurry KR, Duncan SR. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med. 2003;167(9):1271–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 2001;59(1):260–9.PubMedCrossRefGoogle Scholar
  56. 56.
    McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948–67.PubMedCrossRefGoogle Scholar
  57. 57.
    Davis Jr RD, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg. 2003;125(3):533–42.PubMedCrossRefGoogle Scholar
  58. 58.
    Zheng C, Kane TD, Kurland G, Irlano K, Spahr J, Potoka DA, et al. Feasibility of laparoscopic Nissen fundoplication after pediatric lung or heart-lung transplantation: should this be the standard? Surg Endosc. 2011;25(1):249–54.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Portex Respiratory UnitUCL Institute of Child HealthLondonUK
  2. 2.Department of Pediatric Respiratory MedicineThe Children’s Hospital at WestmeadWestmead, SydneyAustralia
  3. 3.Department of Paediatric Respiratory MedicineGreat Ormond Street Hospital for ChildrenLondonUK

Personalised recommendations